Canopy Growth Corp. (TSX: WEED) (NYSE: CGC), together with Canopy Rivers Corp., announced in a recent news release that they have filed an early warning report in connection with the closing of the qualifying transaction of LiveWell Canada Inc., formerly Percy Street Capital Corporation, under National Instrument 62-103. Per the transaction, the two companies received a total of 17,589,552 common shares of Livewell in exchange for their common shares of LiveWell Foods Canada Inc. Canopy Growth holds 11,726,364 common shares and Canopy Rivers holds 5,863,188 common shares. Prior to the transaction, neither company held any common shares or convertible securities of LiveWell. Certain common shares held by the companies are subject to regulatory escrow provisions. At the time of the news release, the companies did not intend to take any further action, although they are permitted to acquire additional securities, dispose of some or all the securities or continue to hold the common shares, warrants or other securities of LiveWell.
To view the full press release, visit http://cnw.fm/Ek5C7
About Canopy Growth Corporation
Canopy Growth is a diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates ten licensed cannabis production sites with over 2.4 million square feet of production capacity, including over 500,000 square feet of GMP-certified production space. The company has operations in 11 countries across five continents. The company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector. From its historic public listing on the Toronto Stock Exchange and New York Stock Exchange to its continued international expansion, pride in advancing shareholder value through leadership is engrained in everything Canopy Growth does. For more information visit www.CanopyGrowth.com.
More from CannabisNewsBreaks
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
